On May 5, 2023, Gilead Sciences Inc announced that at its annual meeting of shareholders held on May 3, 2023, a shareholder proposal requesting the Company to amend the company governing documents to give street name shares and non-street name shares an equal right to call a special stockholder meeting was not approved and Company board nominee Anthony Welters nomination was approved by shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.61 USD | -1.58% |
|
+10.23% | -14.07% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.07% | 86.72B | |
+55.19% | 815B | |
+47.26% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.40% | 247B | |
+3.64% | 229B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Declaration of Voting Results by Gilead Sciences Inc